Valerius Biopharma AG develop biosimilar drugs for therapeutic indications with high medical need. The product pipeline consists of four orphan and non-orphan biosimilar drugs that will be developed according to highest regulatory standards to enable global access for patients at affordable prices.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business

You may also be interested in